TerminatedNot Applicable

Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients

Stopped: Sponsor decision

China215 participantsStarted 2014-11-10

Plain-language summary

Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese patients.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patients who implanted with Magna Ease Heart Valve (Type:7300TFX and 3300TFX) in Fuwai Hospital in China. * The patients agree to sign the inform consent form (ICF). Exclusion Criteria: * No specific exclusion criteria.

What they're measuring

Echocardiography to evaluate the performance of heart valve

Timeframe: Up to five years after surgery

Trial details

NCT IDNCT02523066

SponsorEdwards Lifesciences

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2017-04-29

View on ClinicalTrials.gov More Mitral Valve or Aortic Valve Replacement trials